Save New Eucrisa as an Eczema Option After Topical Steroids

February 2017

The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.

Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.

Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Consider Risks and Benefits When Choosing Metformin Add-Ons
Smoking Cessation Feel Comfortable Using Chantix in Patients With STABLE Psychiatric Conditions
COPD Use Inhaled Steroids Less Often for COPD
NSAIDs Feel Comfortable Giving NSAIDs After Most Fractures
Epinephrine Choose "Epinephrine Auto-Injector" So Patients Can Get the Product They Prefer
Muscle Relaxants Limit Use of Muscle Relaxants to 7 Days for Acute Low Back Pain
Hypotension Consider Med Causes and Suggest Nondrug Measures in Orthostatic Patients
Renal & Urology Use Alpha-Blockers in Patients With Kidney Stones About 5 mm to 10 mm in Size
Eczema Save New Eucrisa as an Eczema Option After Topical Steroids
Surgery Consider Stopping ACEIs and ARBs Preoperatively in Some Patients
Interactions Watch for Statin Interactions With Pradaxa
COPD Use Inhaled Steroids Less Often for COPD